MIM
LIN icon

MetLife Investment Management’s Linde LIN Stock Holding History

MetLife Investment Management’s Portfolio LIN Stock Details LIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$54.1M Sell
109,153
-2,831
-3% -$1.34M 0.28% 44
2025
Q4 		$47.7M Sell
111,984
-4,375
-4% -$1.87M 0.23% 61
2025
Q3 		$55.3M Sell
116,359
-3,569
-3% -$1.69M 0.27% 47
2025
Q2 		$56.3M Sell
119,928
-3,828
-3% -$1.75M 0.33% 39
2025
Q1 		$57.6M Sell
123,756
-2,354
-2% -$1.06M 0.31% 41
2024
Q4 		$52.8M Buy
126,110
+1,110
+0.9% +$506K 0.29% 45
2024
Q3 		$59.6M Sell
125,000
-3,221
-3% -$1.47M 0.34% 36
2024
Q2 		$56.3M Buy
128,221
+12,801
+11% +$5.63M 0.33% 39
2024
Q1 		$53.6M Sell
115,420
-4,169
-3% -$1.81M 0.36% 36
2023
Q4 		$49.1M Sell
119,589
-3,081
-3% -$1.21M 0.35% 40
2023
Q3 		$45.7M Sell
122,670
-3,544
-3% -$1.35M 0.36% 38
2023
Q2 		$48.1M Sell
126,214
-5,075
-4% -$1.85M 0.35% 42
2023
Q1 		$46.7M Sell
131,289
-1,959
-1% -$656K 0.34% 40
2022
Q4 		$43.5M Sell
133,248
-3,508
-3% -$1.1M 0.33% 40
2022
Q3 		$36.9M Sell
136,756
-3,138
-2% -$901K 0.31% 49
2022
Q2 		$40.2M Buy
139,894
+10,686
+8% +$3.34M 0.31% 54
2022
Q1 		$41.3M Buy
129,208
+15,963
+14% +$4.94M 0.27% 63
2021
Q4 		$39.2M Sell
113,245
-3,392
-3% -$1.1M 0.32% 55
2021
Q3 		$34.2M Sell
116,637
-3,971
-3% -$1.21M 0.31% 54
2021
Q2 		$34.9M Sell
120,608
-3,984
-3% -$1.16M 0.31% 58
2021
Q1 		$34.9M Sell
124,592
-2,872
-2% -$745K 0.32% 56
2020
Q4 		$33.6M Sell
127,464
-5,738
-4% -$1.41M 0.32% 54
2020
Q3 		$31.7M Sell
133,202
-4,154
-3% -$1.01M 0.35% 54
2020
Q2 		$29.1M Sell
137,356
-1,108
-0.8% -$214K 0.33% 54
2020
Q1 		$24M Sell
138,464
-4,237
-3% -$836K 0.33% 61
2019
Q4 		$30.4M Sell
142,701
-4,414
-3% -$889K 0.32% 61
2019
Q3 		$28.5M Sell
147,115
-2,493
-2% -$483K 0.31% 61
2019
Q2 		$30M Sell
149,608
-7,037
-4% -$1.32M 0.32% 55
2019
Q1 		$27.6M Buy
+156,645
New +$26M 0.3% 64

Other funds holding LIN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MetLife Investment Management's LIN Position: Q1 2026 in Review

MetLife Investment Management reduced its Linde (LIN) stake by 2.5% in Q1 2026, selling an estimated $1.34M and leaving 109,153 shares worth $54.1M. The position accounts for 0.28% of the portfolio, ranked #44.

MetLife Investment Management first reported a position in LIN in Q1 2019 and has held it in 29 quarters since. The position peaked at $59.6M in Q3 2024. 2,267 funds tracked by Wall St. Rank hold LIN as of Q1 2026.

  • MetLife Investment Management held 109,153 shares of Linde worth $54.1M as of Q1 2026.
  • MetLife Investment Management sold 2,831 Linde shares in Q1 2026, an estimated $1.34M.
  • Linde made up 0.28% of MetLife Investment Management's portfolio in Q1 2026, its #44 holding.
  • MetLife Investment Management first reported a position in Linde in Q1 2019 and has held it in 29 quarters since.
  • MetLife Investment Management's Linde position peaked at $59.6M in Q3 2024.
  • 2,267 funds tracked by Wall St. Rank held Linde as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.